Alzheon, Inc., a clinical-stage biopharmaceutical company developing investigational therapies and diagnostic assays for ...
Tracking microstructural shifts in nerve tracts The research team identified these anatomical modifications using diffusion ...
Phase 3 and Phase 2 Studies in APOE4/4 Alzheimer's Patients Show Favorable Safety, Low Risk for Brain Bleed and Edema (ARIA), and Neurovascular Protection. Long-Term Phase 3 and P ...
Remepy, a pioneer in Hybrid Drugs™, today announced the publication of new mechanistic findings in npj Parkinson's Disease (Nature Portfolio). The study provides insight, for the first time, into ...
The cerebellum, historically linked only to motor control, is now recognized as a vital hub for executive function, emotion, and social cognition. Through ...
A modern personal injury case is won or lost long before anyone enters a courtroom. The decisive work now happens in data: ...
ME/CFS brain fog is measurable on an MRI - new research links impaired glymphatic waste clearance to sleep disruption and ...
Scientists at Rice University have produced the first full, dye-free molecular atlas of an Alzheimer’s brain. By combining laser-based imaging with machine learning, they uncovered chemical changes ...